Research by Jakub Hlavka and colleagues suggests a combination of brief cognitive tests and blood-based biomarker tests will allow primary care physicians to identify patients with potential early stage Alzheimer’s disease efficiently and triage them for further evaluation.
Other featured articles
Extended-Release Formulation and Medication Adherence
Suboptimal adherence to chronic medications undermines treatment effectiveness and costs the U.S. as much as $289 billion annually. This is the first study to analyze the impact of extended-release formulations on long-term adherence.
Prescription Opioid Use in General and Pediatric Emergency Departments
Children, adolescents, and young adults treated in pediatric emergency departments are much less likely to be prescribed opioids compared to patients of similar age and ailment treated at general EDs.
Expanding the Role of the Patient-Centered Outcomes Research Institute: Reauthorization and Facilitating Value Assessments
Should Congress reauthorize funding for the Patient-Centered Outcomes Research Institute (PCORI)? Professor William Padula writes the PCORI can generate research relevant for shifting to value-based healthcare.
Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes?
This study provides the first evidence to our knowledge that near-universal access to Medicare at age 65 is associated with improvements in population-level cancer mortality, and provides new evidence on the differences in the impact of health insurance by gender.